This systematic review and dose-response meta-analysis aims to evaluate the association between hepatic steatosis severity and the risk of major adverse cardiovascular events, including myocardial infarction, stroke, cardiovascular mortality, and heart failure, in patients with non-alcoholic fatty liver disease.Click-Here-(Apply Form).comCall for Co-AuthorsWe are pleased to announce an open call for:
8 Co-authorship slots on our upcoming cross sectional.
• Prior research or publication experience is not required, we welcome new authors.
• Open to medical students (undergraduate and postgraduate), residents, and MDs.
• This is an excellent opportunity to gain authorship experience and contribute to a published work.
Deadline: January 15, 2026, at 11:59 PMFill out the form at the link above.
Slots are limited please apply promptly.